ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Human Papillomavirus Vaccine Therapy in Treating Men With HIV-1 Infection

ClinicalTrials.gov ID: NCT00513526

Public ClinicalTrials.gov record NCT00513526. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 18, 2026, 12:42 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Single-Arm, Open-Label Pilot Trial of the Safety and Immunogenicity of a Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Men

Study identification

NCT ID
NCT00513526
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
AIDS Malignancy Consortium
Network
Enrollment
112 participants

Conditions and interventions

Interventions

  • Gardasil Biological

Biological

Eligibility (public fields only)

Age range
18 Years and older
Sex
Male
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 31, 2007
Primary completion
Apr 30, 2010
Completion
Sep 30, 2011
Last update posted
Nov 13, 2023

2007 – 2011

United States locations

U.S. sites
8
U.S. states
5
U.S. cities
7
Facility City State ZIP Site status
UCLA Clinical AIDS Research and Education (CARE) Center Los Angeles California 90095-1793
UCSF Helen Diller Family Comprehensive Cancer Center San Francisco California 94143
Denver Health Medical Center Denver Colorado 80204-4507
Boston University Cancer Research Center Boston Massachusetts 02118
Laser Surgery Care New York New York 10010
New York Weill Cornell Cancer Center at Cornell University New York New York 10021
Montefiore Medical Center The Bronx New York 10461
Benaroya Research Institute at Virginia Mason Medical Center Seattle Washington 98101

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00513526, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 13, 2023 · Synced May 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00513526 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →